Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

Clinical trial NCT00402532 · COMPLETED

Trial details

NCT number: NCT00402532
Sponsor: Hannover Medical School
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Transplantation

Start date: 2005-03-01
Primary completion: 2011-11-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.